Business
PRESSR: Borouge and Mubadala Bio sign partnership agreement to strengthen the UAE's healthcare and life sciences sectors
PRESSR: Borouge and Mubadala Bio sign partnership agreement to strengthen the UAE's healthcare and life sciences sectors
About this update from Borouge Plc
Within the scope of the agreement, the two entities aim to further strengthen the UAE’s domestic manufacturing capabilities and fortify its local supply chainThe agreement intends to meet the demand for locally produced, superior-quality medical products, advancing the UAE’s economic resilience and supporting the objectives of the ‘Make it in the Emirates’ initiativeBorouge manufactures first-ever made in the UAE polyolefins product engineered for medical applicationsAgreement signed on the sidelines of the Make it in the Emirates event, supporting the UAE’s ambitious ‘Operation 300 Billion’ strategyABU DHABI, UAE: Borouge, a leading petrochemicals company, that provides innovative and differentiated polyolefins solutions, has signed a strategic cooperation agreement with Mubadala Bio, a life sciences company dedicated to pursuing better health outcomes for the UAE and beyond. The partnership will explore the supply of polyolefin materials to enable local manufacturing of medical products, reinforcing local manufacturing capabilities while contributing to the future of the UAE’s healthcare and life sciences sectors.The signing ceremony was witnessed by His Excellency Dr Sultan Al Jaber, UAE Minister of Industry and Advanced Technology and ADNOC Managing Director and Group CEO, Dr. Bakheet Al Katheeri, CEO UAE investments Mubadala, and Ismail Ali Abdulla, Executive Director of UAE Clusters, Mubadala. Hazeem Sultan Al Suwaidi, CEO of Borouge, and Hamad Husein Almarzooqi, Deputy CEO of Mubadala Bio, signed the agreement during Make it in the Emirates, a flagship UAE event that unites industry leaders to drive innovation and industrial growth.Hazeem Sultan Al Suwaidi, CEO of Borouge, said, “We are delighted to partner with Mubadala Bio to explore the development of essential medical solutions made at our Ruwais facility in the UAE. Aligned with the ambitions of ‘Make it in the Emirates’, this collaboration goes beyond the supply of materials, it is about combining the UAE’s scientific product innovation with regional insight to bring smarter, safer products for patients and clinicians across the Middle East and beyond.”Ismail Ali Abdulla, Executive Director of UAE Clusters at Mubadala's UAE Investments Platform, added, “This collaboration agreement with Borouge reflects Mubadala Bio’s commitment to enabling a world-class, sustainable life sciences sector anch...